Investor Presentaiton

IV Appendix Income Statement In EGP Gross Revenue 1 Net Revenue Cost Of Revenue Gross Profit Gross Profit Margin Selling, General & Administrative Penalties On Returned Checks EBITDA EBITDA Margin Depreciation & Amortization EBIT EBIT Margin Financial Expenses Other Expenses Other Income EBT EBT Margin Differed Tax Income Tax Net Profit Net Profit Margin ibnsinapharma Source: Company Management (1) Gross revenue includes transportation revenue (audited) (audited) (audited) (audited) 2014 2015 2016 2017 YoY Change ('16-'17) 4,301,516 5,439,119 7,372,467 9,818,405 33.2% 4,197,376 5,327,728 7,205,983 9,586,344 (3,889,670) (4,931,515) (6,636,864) (8,759,914) 307,706 7.2% 396,213 569,118 826,430 45.2% (187,399) 7.3% (244,459) 7.7% (346,502) 8.4% (431,815) 24.6% 1,792 3,296 122,099 155,050 5,579 228,195 11,241 405,856 77.9% 2.8% 2.9% 3.1% 4.1% (11,037) (18,792) (26,790) (31,097) 111,062 136,258 201,406 374,760 86.1% 2.6% 2.5% 2.7% (48,880) (56,331) (7,408) (5,912) (74,272) (3,173) 7,481 1,873 9,137 3.8% (115,830) (37,559) 6,326 62,255 75,888 133,098 227,697 71.1% 1.4% 1.4% 1.8% 2.3% (2,379) 3,035 4,793 (600) (22,335) (21,564) (36,143) (56,960) 37,541 57,358 101,748 170,137 67.2% 0.9% 1.1% 1.4% 1.8% 27

View entire presentation